Avantor (AVTR) Expected to Release Quarterly Earnings on Wednesday

Key Points

• Avantor is expected to report Q3 2026 results before market open on October 28. Analysts forecast earnings of $0.2076 per share and revenue of $1.64 billion, while full-year EPS guidance remains $0.800–$0.830.
• In its previous quarter, Avantor earned $0.21 per share, beating estimates of $0.19, and generated $1.69 billion in revenue versus expectations of $1.61 billion. Revenue increased 0.5% year over year.
• Analyst sentiment remains primarily cautious, with 15 Hold ratings, two Buys and one Sell; the consensus price target is $13.06, below the stock’s reported $16.65 price.

Avantor (NYSE:AVTR - Get Free Report) will likely be issuing its Q3 2026 results before the market opens on Wednesday, October 28th. Analysts expect Avantor to post earnings of $0.2076 per share and revenue of $1.64 billion for the quarter. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. Interested persons may visit the company's upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Wednesday, October 28, 2026 at 8:00 AM ET.

Avantor (NYSE:AVTR - Get Free Report) last announced its quarterly earnings results on Wednesday, July 29th. The company reported $0.21 earnings per share for the quarter, beating analysts' consensus estimates of $0.19 by $0.02. The business had revenue of $1.69 billion during the quarter, compared to analysts' expectations of $1.61 billion. Avantor had a positive return on equity of 9.92% and a negative net margin of 8.81%. During the same quarter last year, the business posted $0.24 earnings per share. The business's revenue for the quarter was up .5% on a year-over-year basis. On average, analysts expect Avantor to post $0.81 EPS for the current fiscal year and $0.87 EPS for the next fiscal year.

Avantor Stock Performance

NYSE AVTR opened at $16.65 on Wednesday. The company has a quick ratio of 1.18, a current ratio of 1.78 and a debt-to-equity ratio of 0.65. Avantor has a fifty-two week low of $7.26 and a fifty-two week high of $16.83. The business has a fifty day moving average of $15.01 and a 200-day moving average of $11.55. The stock has a market cap of $11.26 billion, a price-to-earnings ratio of -19.82, a price-to-earnings-growth ratio of 9.26 and a beta of 0.94.

Wall Street Analysts Forecast Growth

AVTR has been the topic of several recent analyst reports. TD Cowen increased their target price on Avantor from $15.00 to $17.00 and gave the stock a "hold" rating in a research report on Tuesday, October 13th. Stifel Nicolaus lifted their price target on Avantor from $8.00 to $15.00 and gave the company a "hold" rating in a report on Thursday, July 30th. Evercore set a $10.50 price target on Avantor in a report on Monday, July 6th. Wall Street Zen raised shares of Avantor from a "hold" rating to a "buy" rating in a research note on Sunday, October 11th. Finally, Jefferies Financial Group raised shares of Avantor from an "underperform" rating to a "hold" rating and set a $13.00 price objective for the company in a research note on Wednesday, July 29th. Two analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Hold" and a consensus target price of $13.06.

Avantor Company Profile

Avantor, Inc is a global provider of mission-critical products and services used in the life sciences, healthcare, education, and advanced technology industries. The company supplies chemicals, reagents, laboratory consumables, equipment, and other materials used in research, development, manufacturing, and quality-control activities.

Avantor also provides specialized solutions for biopharmaceutical production, including materials and services that support drug development, biologics manufacturing, and other bioprocessing applications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.